FDA Inspection 918008 — Zhejiang Hisun Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Hisun Pharmaceutical Co., Ltd. on Mar 7, 2015 in Taizhou. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Mar 7, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)